ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$54.11
*  
0.89
 negative 
1.67%
Get ALNY Alerts
*Delayed - data as of Apr. 16, 2014 14:13 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALNY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Alnylam/Isis's Regulus to Go Public - Analyst Blog
8/22/2012 7:18:01 PM - Zacks.com

Biogen Inks Deal with Regulus - Analyst Blog
8/16/2012 6:22:50 PM - Zacks.com

Alnylam Pharma Revs In-Line - Analyst Blog
8/7/2012 3:08:01 PM - Zacks.com

Alnylam Earns Milestone Payment - Analyst Blog
8/6/2012 4:15:01 PM - Zacks.com

Zacks #1 Rank Additions for Monday - Tale of the Tape
8/6/2012 9:14:01 AM - Zacks.com

Zacks #1 Rank Additions for Thursday - Tale of the Tape
8/2/2012 9:14:01 AM - Zacks.com

Zacks #1 Rank Additions for Friday - Tale of the Tape
7/27/2012 9:14:01 AM - Zacks.com

Zacks #1 Rank Additions for Tuesday - Tale of the Tape
7/24/2012 9:11:09 AM - Zacks.com

Positive Data on Alnylam Candidate - Analyst Blog
7/23/2012 5:09:37 PM - Zacks.com

Zacks #1 Rank Additions for Friday - Tale of the Tape
7/20/2012 9:10:23 AM - Zacks.com

Company News for July 17, 2012 - Corporate Summary
7/17/2012 9:47:26 AM - Zacks.com

Alnylam Inks Oncology Deal - Analyst Blog
7/13/2012 4:47:38 PM - Zacks.com

Orphan Status for Alnylam Drug - Analyst Blog
6/21/2012 10:45:01 AM - Zacks.com

How the Short Ratio Can Lead to Big Gains - Screen of the Week
6/12/2012 1:00:01 AM - Zacks.com

Alnylam Narrows Loss - Analyst Blog
5/4/2012 1:38:01 PM - Zacks.com

The Zacks Analyst Blog Highlights: Amgen, Sanofi, Regeneron, Alnylam and Coach - Press Releases
3/28/2012 9:24:38 AM - Zacks.com

Encouraging Data on Amgen Candidate - Analyst Blog
3/27/2012 12:22:16 PM - Zacks.com

What Alnylam Doesn't Want You To Know
3/16/2012 9:54:00 AM - Seeking Alpha

Good News For Alnylam: PBL Making Baulcombe Patent Widely Available
3/11/2012 11:18:00 AM - Seeking Alpha

Diabetes Market: Eli Lilly's Classic Pharma Vs. Sanofi Aventis' Modern Synergy
3/8/2012 6:24:00 PM - Seeking Alpha

Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts
3/7/2012 8:13:00 AM - Seeking Alpha

Noteworthy Insider Buys And Sells In Healthcare On Wednesday To Friday
2/26/2012 4:10:00 AM - Seeking Alpha

11 Takeover/LBO Targets With Increasing Short Interest
2/22/2012 11:59:00 PM - Seeking Alpha

Company News for February 15, 2012 - Corporate Summary
2/15/2012 10:10:01 AM - Zacks.com

Alnylam Delivers In-Line Numbers - Analyst Blog
2/13/2012 10:00:01 AM - Zacks.com